MYOPROSP - a Prospective Cohort Study in Myositis
A legfontosabb adatok
- Ki végzi
- University of Manchester
- Hol
- Egyesült Királyság1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Fut, nem toboroz
- Résztvevők
- 300 fő, tervezett
- Kezdés
- 2016. okt. 4.
- Várható befejezés
- 2030. dec.
- A vizsgálat típusa
- Megfigyeléses
- A regiszteradat frissítve
- 2025. április 3.
Ki vehet részt
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 26 feltétel megnézéseKevesebb
Ki vehet részt
- Polymyositis
- Dermatomyositis (including amyopathic)
- Inclusion body myositis
- Anti-synthetase syndrome
- Myositis overlapping with another connective tissue disorder
- Cancer-associated myositis
- Immune-mediated necrotising myopathy including statin-induced myositis
- Juvenile myositis persisting into adulthood
- Fasciitis including eosinophilic myofasciitis
- Vasculitis affecting muscle
- Granulomatous myositis
- Focal myositis
- Orbital myositis
- Suspected myositis under investigation
- CTD features in association with a myositis specific / associated antibody
Ki nem vehet részt
- Myositis secondary to alcohol or drug abuse
- Patients with disease duration >2 years
- Patients < 18 years
- Confirmed non-inflammatory myopathies
- Patients unwilling or unable to give consent
- Patients with poor or no venous access
- Patients where MR imaging is contraindicated (for MR substudy); Study population description Patients referred to tertiary level UK myositis clinics; Sampling methods N/A, this is a prospective study of consecutive eligible patients
Egyéb feltételek
- Gender Both female and males
- Age limits Patients >/= 18 years
- Accept healthy volunteers No
- Eligibility criteria
Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
Adult patients with suspected or confirmed idiopathic inflammatory myopathy (IIM) will be recruited. Patients will be approached, consented, have baseline demographics, diagnostics and disease activity measures recorded, and blood taken. The collection of data and biological material will mirror usual clinical practice as far as possible. Subjects will ideally attend further visits at 3, 6 and 12 months to have bloods taken, outcome measures recorded and questionnaires completed.
A teljes eredeti leírásKevesebb
In addition, blood, muscle biopsies and imaging undertaken as part of usual care will also be collected for research purposes to measure a number of biomarkers for the assessment of diagnostic accuracy and clinical utility evaluation. As per usual practice, a muscle biopsy will be performed at baseline, and a further biopsy offered at 6 months to assess treatment response. A magnetic resonance (MR) muscle protocol will also be performed as per usual clinical practice, and a gadolinium-enhanced MR heart scan offered. Both these scans will be repeated at 6 months. An existing electronic database entry system will be used for data entry and capture on an anonymised basis.
The study will thus be based around diagnostic evaluations and outcome measures to improve quality of care in IIM.
A vizsgálat csoportja
- Idiopathic Inflammatory Myopathy
PM, DM, sIBM, necrotizing myopathy, anti-synthetase syndrome, suspected myopathy
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- MYOPROSP: A Prospective Cohort Study to Identify a Stratified Approach in the Diagnosis, Treatment and Delivery of Care in Adult Idiopathic Inflammatory Myopathy
- A regiszteradat frissítve
- 2025. április 3.